1016: Randomized Trial of Denosumab Versus Zoledronic Acid in Prostate Cancer Patients with Bone Metastases and Elevated Bone Turnover Markers After Receiving Zoledronic Acid Therapy

2007 ◽  
Vol 177 (4S) ◽  
pp. 335-336
Author(s):  
Linda Bosserman ◽  
Karim Fizazi ◽  
Allan Lipton ◽  
Yasmin Rahim ◽  
Tirzo Suarez ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Zoledronic Acid ◽  
Bone Turnover ◽  
Bone Metastases ◽  
Randomized Trial ◽  
Cancer Patients ◽  
Bone Turnover Markers ◽  
Acid Therapy ◽  
Turnover Markers

Bone turnover markers as predictive tools for skeletal complications in men with metastatic prostate cancer treated with zoledronic acid

The Prostate ◽  
2009 ◽  
Vol 69 (6) ◽  
pp. 624-632 ◽  
Author(s):  
Michael Lein ◽  
Kurt Miller ◽  
Manfred Wirth ◽  
Lothar Weißbach ◽  
Christoph May ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Zoledronic Acid ◽  
Bone Turnover ◽  
Bone Turnover Markers ◽  
Metastatic Prostate Cancer ◽  
Predictive Tools ◽  
Skeletal Complications ◽  
Turnover Markers

Different patterns of change in bone turnover markers during treatment with bone-modifying agents for breast cancer patients with bone metastases

Breast Cancer ◽  
2016 ◽  
Vol 24 (2) ◽  
pp. 245-253 ◽  
Author(s):  
Arisa Nishimukai ◽  
Tomoko Higuchi ◽  
Hiromi Ozawa ◽  
Ayako Yanai ◽  
Yoshimasa Miyagawa ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Bone Turnover ◽  
Bone Metastases ◽  
Cancer Patients ◽  
Bone Turnover Markers ◽  
Breast Cancer Patients ◽  
Turnover Markers
Sign in / Sign up

Export Citation Format

Share Document